Pfizer Inc.PFENYSE
Loading
SG&A Expenses Over TimeStable
Percentile Rank29
3Y CAGR+0.6%
5Y CAGR+3.2%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+0.6%/yr
vs -2.3%/yr prior
5Y CAGR
+3.2%/yr
Consistent
Acceleration
+2.9pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.35B | -9.4% |
| 2024 | $14.73B | +1.8% |
| 2023 | $14.47B | +10.3% |
| 2022 | $13.12B | +7.0% |
| 2021 | $12.25B | +7.5% |
| 2020 | $11.40B | -10.1% |
| 2019 | $12.67B | -11.9% |
| 2018 | $14.38B | -2.4% |
| 2017 | $14.73B | -0.2% |
| 2016 | $14.76B | - |